Díez Pérez, Adolfo
Adolfo Díez-Pérez researcher
VIAF ID: 86829678 (Personal)
Permalink: http://viaf.org/viaf/86829678
Preferred Forms
- 100 0 _ ‡a Adolfo Díez-Pérez ‡c researcher
-
- 100 1 _ ‡a Diez Pérez, Adolfo
- 100 1 0 ‡a Díez Pérez, Adolfo
4xx's: Alternate Name Forms (6)
Works
Title | Sources |
---|---|
Abordaje transvaginal y transrectal con ecografía endocavitaria en drenaje de abscesos pélvicos | |
Adequació de l'eina FRAX per determinar el risc de fractura osteoporòtica en població femenina espanyola : anàlisi de la seva capacitat diagnòstica (discriminativa i predictiva) i calibració en la població femenina espanyola | |
Alteraciones óseas en el alcoholismo crónico | |
Análisis de los efectos a corto y medio plazo de una cura termal en pacientes con patología crónica | |
Característiques del compliment dels tractaments per a l'osteoporosi i característiques dels pacients amb resposta inadequada al tractament a Catalunya | |
The clinical description, molecular etiology, and pathophysiological studies in cutaneous skeletal hypophosphatemia syndrome : a mosaic disorder of activating RAS mutations | |
Efecto de la diabetes mellitus tipo 2 sobre la incidencia de fractura osteoporótica | |
Efecto del tratamiento con probióticos (Saccharomyces boulardii) sobre el microbioma intestinal y la inflamación sistémica en el paciente VIH virológicamente suprimido | |
Effect of IL-1beta, PGE(2), and TGF-beta1 on the expression of OPG and RANKL in normal and osteoporotic primary human osteoblasts. | |
The effect of teriparatide [human parathyroid hormone | |
[Effect of tobacco smoking on leptin serum levels and its relationship with steroid hormones and bone mineral density] | |
Enfermedad ósea en el paciente renal : avances epidemiológicos y diagnósticos | |
Estudio del impacto de la infección por VIH en el metabolismo óseo | |
Estudis de cohorts per validar un model de categorització del risc de fractura per fragilitat en població femenina espanyola en base a l'algoritme FRAX de la OMS. Les cohorts FRIDEX i FROCAT | |
Evaluación de la afectación ósea en pacientes con enfermedades raras | |
[Fragility non-spinal fractures in a cohort of 5,201 women aged 65 years and older during a 3-year follow-up] | |
Functional Assessment of Coding and Regulatory Variants From the <i>DKK1</i> Locus | |
Heterogeneity of biomarker expression in non-small cell lung cancer | |
HIV infection, bone metabolism, and fractures. | |
The impact of common co-morbidities (as measured using the Charlson index) on hip fracture risk in elderly men: a population-based cohort study | |
Indicadores de calidad y de uso de antimicrobianos en pacientes críticos | |
Influència de factors clínics, radiològics i patològics en la valoració de resposta a la quimioteràpia neoadjuvant en càncer de mama | |
International management of bone health in glucocorticoid-exposed individuals in the observational GLOW study | |
[Knowledge of the results of densitometry improves calcium intake in postmenopausal women] | |
A meta-analysis of the association of fracture risk and body mass index in women | |
Microindentation for in vivo measurement of bone tissue mechanical properties in humans. | |
Nuevas fronteras en el estudio de la densidad ósea en la población española | |
Nuevos mecanismos protectores en la enfermedad inflamatoria intestinal : sistema endocannabinoide y haptoglobina | |
Obesity and the Relative Risk of Knee Replacement Surgery in Patients With Knee Osteoarthritis: A Prospective Cohort Study. | |
[Osteoporitic fracture risk factors in Spain] | |
Osteoporosis | |
Polymorphisms and haplotypes across the osteoprotegerin gene associated with bone mineral density and osteoporotic fractures. | |
Prediction of absolute risk of fragility fracture at 10 years in a Spanish population: validation of the WHO FRAX ™ tool in Spain. | |
Predictors of fracture while on treatment with oral bisphosphonates: a population-based cohort study. | |
Probability of fractures predicted by FRAX® and observed incidence in the Spanish ECOSAP Study cohort. | |
Promoter 2 -1025 T/C Polymorphism in the RUNX2 Gene Is Associated with Femoral Neck BMD in Spanish Postmenopausal Women | |
Real-Life and RCT Participants: Alendronate Users Versus FITs' Trial Eligibility Criterion | |
Recommendations for an update of the current | |
Reference data for bone material strength index (BMSI) measured by impact microindentation | |
Relationship among densitometry, bone histomorphometry, and histologic stage in idiopathic myelofibrosis | |
Relationship between mortality and BMI after fracture: a population-based study of men and women aged ≥40 years. | |
Risk factors for prediction of inadequate response to antiresorptives | |
The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). | |
Romosozumab in postmenopausal women with low bone mineral density. | |
Selective estrogen receptor modulators (SERMS). | |
Self-perception of fracture risk: what can it tell us? | |
Situació i avaluació de l’atenció de la fractura de maluc en la gent gran a Catalunya : estudi poblacional entre els anys 2012 i 2016 | |
Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study. | |
Socioeconomic status and its association with the risk of developing hip fractures: a region-wide ecological study. | |
Switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: changes in bone turnover markers and circulating sclerostin levels. | |
The tissue diagnostic instrument. | |
Tratamiento hospitalario de la fractura de fémur en España: variabilidad y tendencias | |
Treatment with raloxifene for 2 years increases vertebral bone mineral density as measured by volumetric quantitative computed tomography. | |
Vitamin D threshold to prevent aromatase inhibitor-related bone loss: the B-ABLE prospective cohort study. |